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Background: Canine distemper virus (CDV) has been associated with outbreaks of canine infectious respiratory
disease in shelters and boarding kennel environments. POCKITTM Nucleic Acid Analyzer is a field-deployable device
capable of generating automatically interpreted insulated isothermal polymerase chain reaction (iiPCR) results from
extracted nucleic acid within one hour. In this study, reverse transcription iiPCR (RT-iiPCR) was developed to facilitate
point-of-need diagnosis of CDV infection.
Results: Analytical sensitivity (limit of detection 95%) of the established CDV RT-iiPCR was about 11 copies of in vitro
transcribed RNA per reaction. CDV RT-iiPCR generated positive signals from CDV, but not Bordetella bronchiseptica,
canine parvovirus, canine herpesvirus, canine adenovirus 2, canine influenza virus (subtype H3N8), canine parainfluenza
virus, and canine respiratory coronavirus. To evaluate accuracy of the established reaction in canine distemper clinical
diagnosis, 110 specimens from dogs, raccoons, and foxes suspected with CDV infection were tested simultaneously by
CDV RT-iiPCR and real-time RT-PCR. CDV RT-iiPCR demonstrated excellent sensitivity (100%) and specificity (100%),
compared to real-time RT-PCR.
Conclusions: The results indicated an excellent correlation between RT-iiPCR and a reference real time RT-PCR method.
Working in a lyophilized format, the established method has great potential to be used for point-of-care diagnosis of
canine distemper in animals, especially in resource-limited facilities.
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Canine distemper (CD), caused by canine distemper virus
(CDV), is a highly contagious and lethal systemic disease in
young dogs [1]. This virus infects and produces clinical dis-
ease in members of the order Carnivora, including mem-
bers of the families Canidae (fox, coyote, wolf), Mustelidae
(ferret, skunk, badger, mink, weasel, otter, fisher), Procyoni-
dae (raccoon), Felidae (lions, tigers), Ailuridae (red panda),
Hyaenidae (hyenas), Ursidae (bear), and Viverridae (palm
civet, genets) [2].
CDV is a viral disease of global importance in com-
mon and endangered carnivores [3]. CDV contributed to* Correspondence: beckpen@utk.edu
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unless otherwise stated.the endangerment of the North American black-footed
ferret [4], is an emerging disease in the endangered wild
Amur tigers in the Russian Far East [3], and led to the
death of 20% of the Serengeti and Mara lions in the 1990s
[5]. The virus also causes disease in non-carnivores, in-
cluding collared peccaries (Tayassu tajacu) [6], and has re-
cently been detected in macaques (Macaca) in Japan [7]
and China [8].
Raccoons have been implicated in the spread of CDV
to animals in zoo collections and conservation parks
[2], and CDV outbreaks have been documented in rac-
coons living around a suburban zoo [9]. Therefore, do-
mestic dogs are not the only species at risk following
the movement of the distemper virus into a wildlife spe-
cies. CDV produced mass die-offs of thousands of Caspian
seals (Pusa caspica) between 1997 and 2001. The sourceLtd This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Wilkes et al. BMC Veterinary Research 2014, 10:213 Page 2 of 8
http://www.biomedcentral.com/1746-6148/10/213for the epizootic strain is still unknown but thought to be
a terrestrial carnivore [10].
CDV, a member of Morbillivirus genus in the Para-
myxoviridae family, contains a single-stranded, negative-
sense genomic RNA, which is around 15,690-nt long
[11,12]. CDV infection leads to a multi-systemic infection
with signs including respiratory, gastrointestinal and
neurological disorders. CDV has been classified into sev-
eral genetic lineages based on diversity among strains from
distinct geographic locations. There are 7 major CDV line-
ages, America-1, America-2, European, European Wildlife,
Asia-1, Asia-2, and Arctic like [13], as well as some add-
itional proposed ones that have been more recently dis-
covered, including Asia-3 [14], Asia-4 [15], Africa [13],
Europe/South America 1 (European), South America 2,
and South America 3 [16-19]. The Onderstepoort and
Snyder Hill strains, members of the America-1 lineage,
were used widely to produce the distemper vaccines in the
1950s, and these are the same vaccines used today.
Several recent reports suggest both the re-emergence
and increased activity of CDV worldwide [20]. Cases of
CD have also been reported this decade in vaccinated
dogs in Japan [21], Mexico [22], Argentina [16], and the
United States [23]. In each case, the strains associated
with these cases have been shown to be genetically di-
vergent from the vaccine lines. Respiratory and enteric
signs associated with CD may be confused with those of
other respiratory and enteric diseases, hindering early
CDV diagnosis [24,25]. Therefore, rapid and accurate
diagnosis of CDV infection would enable veterinarians
to implement appropriate strategies in time to improve
disease management and prevent outbreaks, particularly
within a shelter environment.
Virus isolation has previously been difficult due to the
lack of an efficient cell line. Engineered VERO cells have
been developed to express the canine signaling lympho-
cyte activation molecule (SLAM; also known as CD150),
which is one of the cellular receptors for canine distem-
per virus (CDV). These engineered cells show cytopathic
effects around one day after inoculation and are highly
sensitive for CDV isolation from canine hosts [26]. How-
ever, there is species-preference for the type of SLAM
receptor [27], which has the potential to affect the ability
to isolate the virus from certain non-carnivore hosts. Add-
itionally, this method requires a cell culture system and is
relatively expensive and labor intensive. CDV immunoas-
says for detection of CDV antigen, such as immunofluor-
escence staining and ELISA [28-32], in general are not
sensitive enough to detect CDV in asymptomatic dogs or
during acute CD infection [31]. Various conventional,
nested, and real-time reverse transcription polymerase
chain reaction (RT-PCR) assays, which offer high degrees of
detection sensitivity and specificity, have also been devel-
oped for CDV [33-42]. However, requiring an experiencedtechnician and a relatively expensive thermocycler, these
assays have been applied to CDV diagnosis mostly in pro-
fessional laboratories. As a result, a rapid, affordable, and
user-friendly platform is still needed for early point-of-care
(POC) detection of CDV infection.
Recently, insulated isothermal PCR (iiPCR), based on
Rayleigh-Bénard convection PCR [43], has been shown to
achieve relatively consistent and fast target amplification
by convective PCR. The reaction is done in a copper ring-
wrapped capillary tube heated within a thermally baffled
device, which is relatively simple and inexpensive [44,45].
In Rayleigh-Bénard convection PCR [43], spontaneous fluid
convection in a cylindrical vessel is driven by temperature
gradients that are formed simply by heating the vessel from
the bottom at a fixed temperature. Reaction constituents
are circulated sequentially through zones of temperature
gradients to allow the denaturation, annealing, and exten-
sion steps of PCR to take place. Because each cycle is
estimated to complete within a few seconds, detectable
amounts of amplicons could be produced within 30 mi-
nutes. For iiPCR, the reaction is performed in a special
capillary tube (namely R-tube™, Figure 1), which is
wrapped with a copper ring near its base. This design
facilitates fast and consistent heating of the fluid at
the bottom end of capillary tubes. Furthermore, fluores-
cent hydrolysis probe technology was integrated into
iiPCR to eliminate post-amplification analysis of ampli-
cons [46]. POCKIT™ Nucleic Acid Analyzer (POCKIT™;
GeneReach, Taichung City, Taiwan) is now available
commercially to perform iiPCR/reverse transcription
(RT)-iiPCR amplification, signal detection and data in-
terpretation (Figure 1). Its temperature program allows
single-tube RT-iiPCR. Fluorescent signals generated
from fluorescent probe hydrolysis are detected and con-
verted to digital signals by the optical and data process-
ing modules integrated in the device. The built-in
algorithms determine the signal-to-noise (S/N) ratio, i.e.
fluorescenceafter iiPCR/fluorescencebefore iiPCR [46] of the
reaction and convert them automatically into simple
readouts (“+”, “−“, or “?”) based on the default thresh-
olds. The results are shown on the display screen within
one hour. Validation of an iiPCR assay for white spot
syndrome virus (WSSV), a shrimp DNA virus, demon-
strated that this system could provide results with sensi-
tivity and specificity comparable to those of a nested
PCR assay within 1 hour for the detection of WSSV in
shrimp samples [47].
Taking advantage of the hydrolysis probe-iiPCR method
and the POCKIT™ device, the aim of this study was to
develop a rapid, sensitive and specific method for CDV de-
tection for points of care. The established CDV RT-iiPCR
method was compared to a real-time RT-PCR [42] to eval-
uated its limit of detection as well as sensitivity and speci-
ficity for the detection of CDV in clinical specimens using
A B
Figure 1 Photograph of POCKIT™ device and R-tube™. The POCKIT™ device (A) is small (28 × 25 × 8.5 cm, W × D × H) and simple to operate.
With a single default program, amplification and product detection steps of both iiPCR and RT-iiPCR could be completed on this device within 1
hour. One to eight reactions could be performed simultaneously in one run. Its simple user interface is accessible via a color touch screen. The
reaction is carried out in a R-tube™ (B), a capillary tube wrapped with a copper ring near its bottom end.
Table 1 Comparison of analytical sensitivity between
validated CDV real-time RT-PCR and RT-iiPCR using viral
RNA of Onderstepoort strain
Sample
dilution
Real-time RT-PCR RT-iiPCR No.
positive/totalNo. positive/total Ct
NTC* - -
Positive control + +
10-1 2/2 34.09 3/3
10-2 2/2 36.99 3/3
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pected to have CDV infection.
Results
CDV RT-iiPCR sensitivity and specificity
The percentage of positive results from in vitro transcribed
RNA dilutions were 100% (21/21), 100.0% (21/21), 95%
(20/21), 25.0% (4/16), and 0% (0/16) for 103, 102, 101, 100,
and 10-1 copies of the RNA standard, respectively.
The ≥95% detection rate and 95% confidence limits,
calculated by probit regression analysis, were 10.1 and
7.6–15.6 copies per reaction, respectively, indicating
that the accuracy of the established reaction was com-
parable to that of the real-time RT-PCR for the detec-
tion of CDV.
Dilutions of the Onderstepoort reference strain, when
tested with both real-time RT-PCR and RT-iiPCR, gener-
ated positive results with all 10-2 dilution samples. At
the 10-3 dilution, 2/3 and 1/2 samples showed positive
signals in RT-iiPCR and real-time RT-PCR, respectively
(Table 1), indicating that the detection limit of RT-iiPCR
was comparable to that of real-time RT-PCR.
During specificity testing, positive signals were gener-
ated only from CDV (Snyder Hill strain) but not from the
other canine pathogens tested (Table 2), indicating that
the established reaction could detect CDV specifically.
Validation of CDV RT-iiPCR using clinical samples
A clinical evaluation was further performed to determine
whether the CDV RT-iiPCR was suitable for detection
of CDV viruses from clinical samples. For this purpose,
110 clinical samples submitted to the University of
Tennessee, College of Veterinary Medicine (UTCVM),
Clinical Virology Lab from 2010 to 2014 were tested by
RT-iiPCR and real-time RT-PCR. These samples in-
cluded strains from 4 different clades of the phylogenetictrees derived from sequences of the H gene and M-F
intergenic region [48]. 100% agreement was found be-
tween the two reactions (56 positive and 54 negative)
(Table 3). No discrepancy was found in samples (13/56)
containing low levels of CDV (Ct > 35, real-time RT-
PCR, indicating that the established method reliably de-
tects low amounts of CDV in clinical samples. Positive
samples had real-time RT-PCR Ct values ranging from
14.31 to 39.41, indicating that the RT-iiPCR was able to
detect viral RNA across the entire range of the assay.
Discussion
In this report, aimed to improve point-of-care diagnosis
of CD, a novel one-tube RT-iiPCR method performed in
a relatively simple field-deployable device, POCKIT™
Nucleic Acid Analyzer, was established for the detection
of CDV in clinical samples. The results show that the
RT-iiPCR was a sensitive and specific test to confirm
CDV infection in dogs with detection limits comparable
to that of the reference real-time RT-PCR.
Table 2 Exclusivity analysis of CDV RT-iiPCR
Pathogen Source RT-iiPCR Real-time
RT PCR (Ct)Results S/N
Canine distemper virus Snyder Hill strain (ATCC) + 1.94 34.45
Bordetella bronchiseptica Clinical sample* - 0.93 Neg
Canine herpesvirus ATCC strain - 0.97 Neg
Canine respiratory coronavirus Clinical sample* - 0.90 Neg
Canine parainfluenza virus ATCC strain - 0.93 Neg
Canine adenovirus 2 ATCC strain - 0.93 Neg
Canine parvovirus Cornell strain - 0.94 Neg
Influenza virus H3N8 Clinical sample* - 0.93 Neg
*Pathogens obtained from clinical samples were previously cultured/isolated and validated by sequencing by the UTCVM Clinical Bacteriology and Virology Labs.
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assays require experienced technicians and costly equip-
ment, limiting their application to professional labora-
tories. Moreover, the nested PCR assay is quite laborious
and time-consuming and requires gel electrophoresis for
amplicon detection, making it prone to cross contamin-
ation. Recently developed miniaturized chips have pro-
gressed by the introduction of microfluid technology for
pathogen detection [49-51]. However, high costs of the
reaction vessels and instruments, problems in product
manufacturing, and sub-optimal detection methods have
deferred these methods from being applied to point-of-
care diagnostics for resource-poor facilities.
In convective PCR, PCR cycling could be accomplished
at high speeds using a single simple heater. Combining
iiPCR and 5′ nuclease-based signal detection, automatic-
ally interpreted results of the established CDV reaction
were generated within one hour in the POCKIT™ device.
Hence, taking sample collection and nucleic acid extrac-
tion into account, the procedure could be completed
within 1.5 hours. Both cDNA synthesis and PCR amplifi-
cation are performed in a single step, eliminating the add-
itional pipetting steps as well as minimizing the risks of
contamination. Furthermore, different types of clinical
samples (including swabs, urine, and tissues) were shown
to be suitable sample types for CDV RT-iiPCR in this
study. Purification of nucleic acids before PCR in general
is required for successful target amplification because Taq
DNA polymerase used in PCR is sensitive to inhibitors
originating from samples and/or the purification processesTable 3 Comparison of CDV RT-iiPCR versus CDV real-time
RT-PCR for the detection of CDV in 110 samples
Real-time RT-PCR
Positive Negative Total
RT-iiPCR Positive 56 0 56
Negative 0 54 54
Total 56 54 110[52]. Inhibitors often decrease assay sensitivity or even
lead to false-negative results. For easy preparation of nu-
cleic acids for CDV RT-iiPCR at POC settings, PetNAD™
Nucleic Acid Co-prep kit (GeneReach USA), a column-
based simple nucleic acid extraction method, is an option
for whole blood, urine, oropharyngeal swab, conjunctival
swab, and nasal swab samples.
The POCKIT™ system is a field portable device, which is
enabled by its small size (28 × 25 × 8.5 cm, W×D×H),
light weight (2.1 kg), and ruggedness. The device has
passed the atmospheric preconditioning, atmospheric con-
ditioning, compression, vibration, shock, and vibration
tests specified in the International Safe Transit Association
(ISTA) Procedure 2A 2011. Another important feature for
the POCKIT™ device to be field deployable is that it could
be operated with a rechargeable battery or car battery,
allowing application of this system in low resource settings
with unstable electricity supply. Furthermore, working in a
lyophilized format, the reagents could be shipped and
stored without the need for refrigeration.
CDV is not a zoonotic pathogen and pathological waste
in general could be placed in a plastic bag to be disposed
of as regular solid waste (www.epa.state.oh.us/dsiwm).
Furthermore, disposables (such as R-tube™, Eppendorf
tubes, and micropipette tips) used in the RT-iiPCR/
POCKIT™ tests are of small sizes. Therefore, for tests per-
formed outside of the office/laboratory, infectious wastes
generated from this test could be packed with double leak-
proof plastic bags or biohazard bags to be treated locally
or taken back to the office/laboratory for disposal. The
disposal should follow the current Biosafety guidelines.
Instead of sending specimens to a diagnostic laboratory,
on-site diagnosis of CDV infection could eliminate ship-
ping and processing costs and shorten test turn-around
time significantly to improve disease management. For ca-
nine infectious respiratory disease in shelters and boarding
kennel environments, this would allow appropriate quar-
antine and management of infected dogs. Additionally,
this method identifies a conserved region of the genome
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raccoons and foxes in this study. Therefore, the estab-
lished method could be utilized potentially in the field for
CDV surveillance in wildlife populations.
Conclusions
In summary, the novel features of the CDV RT-iiPCR
with POCKIT™ method enabled automatic result inter-
pretation of CDV RNA detection in a portable device
with sensitivity and specificity comparable to real-time
RT-PCR. This field-deployable assay could serve as a




Reference strains used included the Snyder Hill strain
(ATCC, Manassas, VA, USA), an isolate from the brain of a
dog in Ithaca, New York, in 1950s and the Onderstepoort
strain, originating from a disease outbreak among North
American ranched foxes in the 1930s.
Clinical samples used were samples submitted to the
UTCVM Clinical Virology Lab between 2010 and 2014
for real-time RT-PCR analysis for CDV. Submissions were
mainly from eastern Tennessee, but samples from Canada,
Texas, Washington, Kentucky, West Virginia, Virginia,
South Carolina, and Pennsylvania were also tested. Most
samples were from dogs (including nasal/oropharyngeal
swabs and urine), but tissues from raccoons and foxes
were also included. These samples were diagnostic sam-
ples submitted to the lab for routine testing and not col-
lected specifically from research animals for research
purposes; therefore, this was exempt from requiring Insti-
tutional Animal Care and Use Committee approval.
RNA extraction
RNA was extracted from clinical samples (including naso-
pharyngeal/conjunctival swabs, urine, and tissues) and dilu-
tions of reference strains with the QIAamp viral RNA kit
(Qiagen, Valencia, CA, USA) according to the manufac-
turer’s instructions. Tissues were macerated with an equalTable 4 Primers and probes used in cloning, CDV RT-iiPCR an









*Nucleotide position is based on GenBank accession no. AF305419.1; aElia et al. [42volume of PBS in a Stomacher (Tekmar Company,
Cincinnati, OH, USA) and supernatant was used for
extraction. Samples previously extracted were stored
at -80°C.Plasmid construction and standard RNA preparation
To generate the standard template (pT-CDV), a 1463-bp
partial cDNA sequence of the nucleocapsid (N) gene
amplified by RT-PCR (primers CDV F1 and CDV R1463,
Table 4) was cloned into the pCR2.1TOPO vector (Invi-
trogen, Carlsbad, CA). Calculation of copy number was
based on the concentrations determined by a DU730
spectrophotometer (Beckman Coulter, Brea, CA, USA).
Dilutions of standard DNA were prepared in TE buffer
(10 mM Tris–HCl and 1 mM EDTA, pH 8.0) containing
30 ng/μl tRNA from Escherichia coli (Sigma-Aldrich,
Milan, Italy) and stored at -20°C. To prepare the RNA
standards, HindIII-linearized pT-CDV plasmid was sub-
jected to in vitro transcription using the MEGAscript T7
Kit (Ambion, Huntingdon, UK). RNA transcripts were
produced, treated with DNase I, and purified by LiCl
precipitation by following the manufacturer’s instruction.
Copy numbers of RNA transcripts were calculated based
on concentrations determined by a spectrophotometer.
Dilutions of RNA were prepared in TE buffer containing
30 ng/μl tRNA. Aliquots were frozen at −70°C and used
only once.CDV real-time RT-PCR
RNA samples were tested in the UTCVM Clinical Vir-
ology Lab by real-time RT-PCR using the primers and
probe designed by Elia et al. [42] (Table 4). Briefly, the
SuperScript III Platinum One-Step qRT-PCR Kit (Invi-
trogen, Life Technologies, Grand Island, NY, USA) was
used with 300 nM of each primer and 200 nM of probe
in a 25 μL total volume reaction with 5 μL RNA. Ampli-
fication was carried out in a Smart Cycler II (Cepheid,
Sunnyvale, CA, USA) with an initial RT step of 42°C for
30 min., followed by 95°C for 2 min., and 45 cycles of
95°C for 15 sec., 48°C for 1 min. and 60°C for 1 min.d real-time RT-PCR
Note*
CDV real-time RT-PCR forward primera
CDV real-time RT-PCR reverse primera
GC-BHQ1 CDV real-time RT-PCR probea
CDV cloning primer (nt108-134)*
CDV cloning primer (nt1570-1547)*
CDV RT-iiPCR primer (nt291 ~ 313)*
CDV RT-iiPCR primer (nt389 ~ 366)*
NFQ CDV RT-iiPCR probe (nt329 ~ 352)*
].
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The CDV RT-iiPCR was designed on the basis of the
hydrolysis probe-based POCKIT™ method described
previously [46]. The CDV-specific RT-iiPCR primers
(Table 4) were designed on the basis of 90 CDV N se-
quences available in GenBank. These sequences in-
cluded strains collected from dogs, wolves (GenBank
accession no. KF914669.1), foxes (GenBank accession
no. JX681125, EU489475.1, EF445056.1, EF445050.1,
FJ710174.1, and HQ540293.1), and mink (GenBank acces-
sion no. EU375802.1). The N gene contains conserved se-
quences with the highest homology within the genomic
RNA of CDV. Primer and probe pairs were designed ac-
cording to the recommended principles for iiPCR (http://
www.iipcr.com/eweb/uploadfile/20130522114104277.pdf).
Amplicons with major secondary structures were ex-
cluded, based on prediction made by the MFold program
(http://mfold.rna.albany.edu/?q=mfold). The probe was la-
beled with fluorescent reporter dye 6-carboxyfluorescein
(FAM) at the 5′ end and a minor groove binder group
(MGB) with a non-fluorescent quencher (NFQ) at the 3′
end (Applied Biosystems) (Table 4). The MGB group in-
creased the stability and specificity of probe hybridization
[53]. Annealing temperature of the probe was approxi-
mately 10°C higher than those of the iiPCR primers. The
expected size of the amplicon was 99 bp. Components of
the iiPCR reaction were optimized and the final master
mix included the following: forward primer CDViiF, re-
verse primer CDViiR, probe CDViiP, dNTP, Taq DNA
polymerase, MMLV reverse transcriptase, 50 mM Tris–
HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, and 1 mM DTT.
These components were lyophilized. The lyophilized re-
agent was rehydrated with 50 μL of Reconstitution Buffer
(GeneReach USA) before 5 μL of the nucleic acid sample
was added to the mixture. Subsequently, 50 μL of the final
mixture was transferred to an R-tube™ (GeneReach USA),
which was spun briefly in a cubee™ mini centrifuge (Gen-
eReach USA) and placed into the reaction chamber of
POCKIT™ Nucleic Acid Analyzer. The reaction completed
in less than one hour and showed the results on the dis-
play screen. Using an optical detection module similar to a
previously described iiPCR device [46], POCKIT™ collects
optical signals through an integrated circuits controller-
regulated sensor. The collected fluorescent signal-to-noise
ratios (signalafter/signalbefore) were converted to posi-
tive (+symbol), negative (- symbol), and indeterminate
(? symbol) according to the default S/N thresholds
[44,46]. A “?” result indicated that the signals were am-
biguous and the sample should be tested again.
CDV RT-iiPCR sensitivity and specificity
Analytical sensitivity of the final CDV RT-iiPCR was deter-
mined by using 10-fold serial dilutions of in vitro tran-
scribed RNA. Each dilution of the in vitro transcribedRNA was tested 16 or 21 times. To further evaluate the
sensitivity of the CDV RT-iiPCR, triplicates of 10-fold ser-
ial dilutions of CDV Onderstepoort strain were subjected
to RNA extraction and analyzed by RT-iiPCR and the ref-
erence real-time RT-PCR in parallel.
To evaluate specificity of CDV RT-iiPCR, nucleic acid
extracts of common canine respiratory pathogens, includ-
ing Bordetella bronchiseptica, canine parvovirus, canine
herpesvirus, canine adenovirus 2, canine influenza virus
(subtype H3N8), canine parainfluenza virus, and canine
respiratory coronavirus, were subjected to CDV RT-iiPCR
analysis. RNA extracted from the Snyder Hill reference
strain was used as a positive control in this experiment.
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